Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
David H. Gutmann
Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
1999
The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2
10.1001/jama.1997.03550010065042 · 1997
Plexiform neurofibroma
10.1002/(sici)1096-8628(19990326)89:1<31::aid-ajmg7>3.0.co;2-w · 1999
Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 optic pathway glioma task force
10.1002/ana.410410204 · 1997
Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders
10.1056/nejm199706123362404 · 1997
Cognitive function and academic performance in neurofibromatosis 1: consensus statement from the NF1 cognitive disorders task force
10.1212/wnl.48.4.1121 · 1997
Unresolved referenced work
1994
A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations
10.1016/0092-8674(90)90253-b · 1990
Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
10.1016/0092-8674(90)90252-a · 1990
Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients
10.1126/science.2134734 · 1990
cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product
10.1016/0888-7543(91)90017-9 · 1991
The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells and oligodendrocytes
10.1016/0896-6273(92)90270-n · 1992
Identification and characterization of the neurofibromatosis type 1 gene product
10.1073/pnas.88.22.9914 · 1991
Identification of the neurofibromatosis type 1 gene product
10.1073/pnas.88.21.9658 · 1991
Characterization of fulllength neurofibromin: tubulin inhibits Ras GAP activity
10.1002/j.1460-2075.1993.tb05841.x · 1993
The neurofibromatosis type 1 gene product, neurofibromin, associates with microtubules
10.1007/bf01233074 · 1993
Differential localization of the neurofibromatosis 1 (NF1) gene product, neurofibromin, with the F-actin or microtubule cytoskeleton during differentiation of telencephalic neurons
10.1016/s0165-3806(01)00190-0 · 2001
The neurofibromatosis type 1 gene encodes a protein related to GAP
10.1016/0092-8674(90)90024-9 · 1990
Increasing complexity of the Ras signaling pathway
10.1074/jbc.273.32.19925 · 1998
Mutation and cancer: statistical study of retinoblastoma
10.1073/pnas.68.4.820 · 1971
Aberrant regulation of ras proteins in tumour cells from type 1 neurofibromatosis patients
10.1038/356713a0 · 1992
Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells
10.1038/ng0296-144 · 1996
Abnormal regulation of mammalian p21'as contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis
10.1016/0092-8674(92)90407-4 · 1992
Loss of neurofibromin is associated with activation of ras/MAPK and P13-K/akt signaling in a neurofibromatosis 1 astrocytoma
10.1093/jnen/59.9.759 · 2000
Single cell Ras-GTP analysis reveals altered ras activity in a single population of neurofibroma Schwann cells but not fibroblasts
10.1074/jbc.m001702200 · 2000
Developmental regulation of a neuron-specific neurofibromatosis 1 (NF1) isoform
10.1002/1531-8249(199911)46:5<777::aid-ana15>3.0.co;2-h · 1999
Expression of two new protein isoforms of the neurofibromatosis type 1 gene product, neurofibromin, in muscle tissues
10.1002/aja.1002020309 · 1995
A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both with GAP activity
10.1128/mcb.13.1.487 · 1993
Expression of the neurofibromatosis 1 (NF1) isoforms in developing and adult rat tissues
1995
Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2
10.1038/363515a0 · 1993
A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor
10.1016/0092-8674(93)90406-g · 1993
ERMMerlin and EBP50 protein families in plasma membrane organization and function
10.1146/annurev.cellbio.16.1.113 · 2000
Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers
10.1093/hmg/3.4.565 · 1994
Alternative transcripts in the mouse neurofibromatosis type 2 (NF2) gene are conserved and code for schwannomins with distinct C-terminal domains
10.1093/hmg/3.7.1075 · 1994
Expression of the neurofibromatosis 2 (NF2) gene isoforms during rat embryonic development
10.1093/hmg/4.3.471 · 1995
Impaired interaction of naturally occurring mutant NF2 protein with actin-based cytoskeleton and membrane
10.1093/hmg/7.2.217 · 1998
Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain
10.1038/sj.onc.1202010 · 1998
Interdomain binding mediates tumor growth suppression by the NF2 gene product
10.1038/sj.onc.1201418 · 1997
Defects in neurofibromatosis 2 protein function can arise at multiple levels
10.1093/hmg/7.3.335 · 1998
Neurofibromatosis 2 tumor suppressor protein, merlin, forms two functionally important intramolecular associations
10.1002/(sici)1097-4547(19991201)58:5<706::aid-jnr12>3.0.co;2-z · 1999
10.1101/gad.226302
10.1101/gad.226302 · doi-reference
The protein 4.1 tumor suppressor, DAL-1, impairs cell motility, but regulates proliferation in a cell-type-specific fashion
10.1006/nbdi.2000.0376 · doi-reference
Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases
10.1093/jnen/59.10.872 · doi-reference
Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas
10.1093/hmg/9.10.1495 · doi-reference
The PEN5 epitope identifies an oligodendrocyte precursor cell population and pilocytic astrocytomas
10.1016/s0002-9440(10)65228-5 · doi-reference
Cancer-related gene expression in neurofibromatosis 1 (NF1)-associated pilocytic astrocytomas
10.1212/wnl.56.7.885 · doi-reference
Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas
10.1046/j.1365-2559.2000.01005.x · doi-reference
Analysis of pilocytic astrocytomas by comparative genomic hybridization
10.1054/bjoc.1999.1066 · doi-reference
Are juvenile pilocytic astrocytomas benign tumors? A cytogenetic study in 24 cases
10.1016/s0165-4608(97)00455-x · doi-reference
Nonrandom chromosomal gains in pilocytic astrocytomas of childhood
10.1016/0046-8177(95)90087-x · doi-reference
Distinctive growth patterns between cerebral and cerebellar astrocytomas-a tissue culture study
10.1111/j.1365-2559.1981.tb01830.x · doi-reference
Astrocytes exhibit regional specificity in gap-junction coupling
10.1002/glia.440110404 · doi-reference
Astrocytes from forebrain, cerebellum, and spinal cord differ in their responses to vasoactive intestinal peptide
10.1111/j.1471-4159.1988.tb01133.x · doi-reference
Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2
10.1101/gad.14.13.1617 · doi-reference
Analysis of molecular domains of epitope-tagged merlin isoforms in Cos-7 cells and primary rat Schwann cells
10.1006/excr.1997.3843 · doi-reference
The NF2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation
10.1101/gad.11.10.1253 · doi-reference
Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein
10.1101/gad.13.8.978 · doi-reference
Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain
10.1101/gad.862101 · doi-reference
Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nfl
10.1038/86898 · doi-reference
Nfl;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects
10.1038/79075 · doi-reference
Mouse tumor model for neurofibromatosis type 1
10.1126/science.286.5447.2176 · doi-reference
Mouse models of tumor development in neurofibromatosis type 1
10.1126/science.286.5447.2172 · doi-reference
Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1
10.1038/nature711 · doi-reference
A mouse model for the learning and memory deficits associated with neurofibromatosis type 1
10.1038/ng0397-281 · doi-reference
Genetic and biochemical evidence that haploinsufficiency of the Nfi tumor suppressor gene modulates melanocyte and mast cell fates in vivo
10.1084/jem.191.1.181 · doi-reference
The Nfi tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts
10.1046/j.1523-1747.1999.00609.x · doi-reference
Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes
10.1093/hmg/10.26.3009 · doi-reference
Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes
10.1002/1098-1136(20010315)33:4<314::aid-glia1030>3.0.co;2-q · doi-reference
Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation
10.1038/sj.onc.1202829 · doi-reference
The neurofibromatosis type 1 (Nfi) tumor suppressor is a modifier of carcinoegn-induced pigmentation and papilloma formation in C57BI/ 6 mice
10.1046/j.1523-1747.2000.00994.x · doi-reference
Neurofibromin negatively regulates neurotrophin signaling through p21-ras in embryonic sensory neurons
10.1006/mcne.2000.0836 · doi-reference
P21 ras and phosphatidylinositol-3 kinase are required for survival of wild-type and NF1 mutant sensory neurons
10.1523/jneurosci.18-24-10420.1998 · doi-reference
Loss of neurofibromin results is neurotrophin-independent survival of embryonic sensory and sympathetic neurons
10.1016/0092-8674(95)90470-0 · doi-reference
Hyperactivation of p21-ras and the hemato poietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro
10.1084/jem.194.1.57 · doi-reference
Nfi regulates hematopoietic progenitor cell growth and ras signaling in response to multiple cytokines
10.1084/jem.187.11.1893 · doi-reference
Nfi deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia
10.1038/ng0296-137 · doi-reference
10.1242/dev.121.11.3583
10.1242/dev.121.11.3583 · doi-reference
Nfi-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farsenyl protein transferase
10.1128/mcb.17.2.862 · doi-reference
Neurofibromin deficiency in mice causes exencephaly and is a modifier for Splotch neural tube defects
10.1006/dbio.1999.9327 · doi-reference
Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart
10.1242/dev.125.22.4359 · doi-reference